The Association Between Liver Function Tests and Some Metabolic Outcomes: Tehran Lipid and Glucose Study
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objectives: Regarding the inconsistent reports on the potential relationship between cardiometabolic disorders, including metabolic syndrome (MetS), diabetes, hypertension (HTN) and chronic kidney disease (CKD), and elevated serum levels of liver enzymes, we conducted this study to test this hypothesis. Methods: Men and women aged ≥ 19 years participated in the sixth examination of Tehran Lipid and Glucose study (TLGS) were recruited. Anthropometric and demographic measurements, as well as biochemical tests, were done for all participants. The odds ratio of cardiometabolic disorders in each tertile category of liver function tests (LFTs), including alanine transaminase (ALT), aspartate transaminase (AST), ALT/AST ratio, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and lactate dehydrogenase (LDH) were estimated using the multivariable logistic regression models. Results: The mean age (± SD) of participants was 48.2 (± 17.1) years, and 42.3% of the participants were men. After adjustment for confounding variables, elevated serum concentrations of ALT, AST, ALT/AST ratio, GGT, and ALP were positively associated with increased chance of develop MetS (OR = 3.80, 95% CI = 2.46 - 5.87 for ALT, OR = 1.52, 95% CI = 1.04-2.23 for AST, OR = 3.08, 95% CI = 2.05 - 4.63 for ALT/AST ratio, OR = 2.71, 95% CI = 1.80 - 4.09 for GGT, OR = 1.64, 95% CI = 1.12 - 2.38 for ALP). Elevated serum concentrations of ALT, ALT/AST ratio, GGT and ALP were also positively associated with risk of diabetes (OR = 4.32, 95% CI = 2.40 - 7.79 for ALT, OR = 3.28, 95% CI = 1.92 - 5.61 for ALT/AST ratio, OR = 2.52, 95% CI = 1.46 - 4.34 for GGT, OR = 1.74, 95% CI = 1.05 - 2.88 for ALP). Also, increased levels of ALT, GGT and ALP were positively associated with HTN (OR = 2.63, 95% CI = 1.66 - 4.17 for ALT, OR = 2.01, 95% CI = 1.30 - 3.13 for GGT, and OR = 1.90, 95% CI = 1.26 - 2.87 for ALP). Moreover, the elevated level of LDH was positively associated with CKD (OR = 2.43, 95% CI = 1.09 - 5.43). Conclusions: Based on the results of the present study, LFT could be helpful for the early detection of cardiometabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990 · cited 1×
“MetS and other cardiometabolic disorders have become major public health concerns with an increasing prevalence worldwide (5, 6).”
Background
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Chu, L. M., Karunanayake, C., Aich, P., Hecker, M., & Pahwa, P. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01124-x · Cited by 4
“38) in elevated ALKP levels compared with the subjects in the first tertile [44].”
Background
Metadata
- Authors
- Gaeini, Z., Bahadoran, Z., Mirmiran, P., & Azizi, F.
- Venue
- Hepatitis Monthly
- Publisher
- Brieflands
- Published
- 2020-05-16
- Volume
- 20
- Issue
- 5
- ISSN
- 1735-143X (ISSN-L)
- 1735-3408
- OpenAlex
- W3025246789
- Cited by
- 22
- References
- 1
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Association Between Liver Function Tests and Some Metabolic Outcomes: Tehran Lipid and Glucose Study. https://app.cochat.ai/papers/10.5812/hepatmon.98535
- The paper
- Gaeini, Z., Bahadoran, Z., Mirmiran, P., & Azizi, F. (2020). The Association Between Liver Function Tests and Some Metabolic Outcomes: Tehran Lipid and Glucose Study. Hepatitis Monthly. https://doi.org/10.5812/hepatmon.98535
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.